budesonide
Drug Details
- Generic Name
- budesonide
- Brand Names
- budesonide, Uceris, BUDESONIDE, Tarpeyo
- Application Number
- ANDA206134
- Sponsor
- Major Pharmaceuticals
- NDC Codes
- 15
- Dosage Forms
- CAPSULE, COATED PELLETS, TABLET, EXTENDED RELEASE, CAPSULE, AEROSOL, FOAM, CAPSULE, DELAYED RELEASE
- Routes
- ORAL, RECTAL
- Active Ingredients
- BUDESONIDE
Indications and Usage
1 INDICATIONS AND USAGE Budesonide inhalation suspension is an inhaled corticosteroid indicated for: • Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age ( 1 ) Limitations of Use : Not indicated for the relief of acute bronchospasm ( 1 ) 1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. Limitations of Use: • Budesonide inhalation suspension is NOT indicated for the relief of acute bronchospasm.